AB Science S.A. ( ABSCF) - Key Metrics
ABSCF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.13 | -$0.06 | -$0.06 |
| 2025Q4 | $0.01 | $0.05 | $0 | $0 |
| 2025Q2 | $0.01 | -$0.09 | -$0.07 | -$0.07 |
| 2024Q4 | $0.01 | -$0.06 | -$0.05 | -$0.05 |
| 2024Q2 | $0.01 | -$0.09 | $0.06 | $0.06 |
ABSCF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.89 |
| 2025Q4 | 0% | 6.25 |
| 2025Q2 | 0% | -3.01 |
| 2024Q4 | 0% | -3.41 |
| 2024Q2 | 0% | -7.27 |
ABSCF
Price: $1.12
52 week price:
Earnings Per Share: -0.03 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 108.1 million